490 related articles for article (PubMed ID: 19073822)
21. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
22. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
23. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
Klapa S; Müller A; Koch A; Kerstein-Stähle A; Kähler W; Heidecke H; Schinke S; Huber-Lang M; Nitschke M; Pitann S; Augustin S; Karsten CM; Riemekasten G; Lamprecht P
Arthritis Rheumatol; 2023 May; 75(5):760-767. PubMed ID: 36409567
[TBL] [Abstract][Full Text] [Related]
24. Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.
van der Veen BS; Petersen AH; Belperio JA; Satchell SC; Mathieson PW; Molema G; Heeringa P
Clin Exp Immunol; 2009 Oct; 158(1):143-53. PubMed ID: 19737241
[TBL] [Abstract][Full Text] [Related]
25. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
26. The interaction between C5a and sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic antibody mediated activation.
Hao J; Huang YM; Zhao MH; Chen M
Arthritis Res Ther; 2014 Jul; 16(4):R142. PubMed ID: 25000985
[TBL] [Abstract][Full Text] [Related]
27. Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.
Bontscho J; Schreiber A; Manz RA; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2011 Feb; 22(2):336-48. PubMed ID: 21233415
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
[TBL] [Abstract][Full Text] [Related]
29. The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Kitching AR; Holdsworth SR
PLoS One; 2018; 13(1):e0190655. PubMed ID: 29315316
[TBL] [Abstract][Full Text] [Related]
30. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Franssen CF; Huitema MG; Muller Kobold AC; Oost-Kort WW; Limburg PC; Tiebosch A; Stegeman CA; Kallenberg CG; Tervaert JW
J Am Soc Nephrol; 1999 Jul; 10(7):1506-15. PubMed ID: 10405206
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
32. Role of C5a-C5aR interaction in sepsis.
Guo RF; Riedemann NC; Ward PA
Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
[TBL] [Abstract][Full Text] [Related]
33. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
34. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies.
Jennette JC; Xiao H; Falk R; Gasim AMH
Contrib Nephrol; 2011; 169():211-220. PubMed ID: 21252521
[TBL] [Abstract][Full Text] [Related]
35. Endothelial NF-
Choi M; Schreiber A; Eulenberg-Gustavus C; Scheidereit C; Kamps J; Kettritz R
J Am Soc Nephrol; 2017 Nov; 28(11):3191-3204. PubMed ID: 28687535
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor.
van den Berg CW; Tambourgi DV; Clark HW; Hoong SJ; Spiller OB; McGreal EP
J Immunol; 2014 Feb; 192(4):1787-95. PubMed ID: 24446515
[TBL] [Abstract][Full Text] [Related]
37. Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
Xiao H; Ciavatta D; Aylor DL; Hu P; de Villena FP; Falk RJ; Jennette JC
Am J Pathol; 2013 Apr; 182(4):1219-26. PubMed ID: 23384999
[TBL] [Abstract][Full Text] [Related]
38. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells.
Kain R; Matsui K; Exner M; Binder S; Schaffner G; Sommer EM; Kerjaschki D
J Exp Med; 1995 Feb; 181(2):585-97. PubMed ID: 7836914
[TBL] [Abstract][Full Text] [Related]
39. [The expression and clinical significance of neutrophil myeloperoxidase in patients with myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
Liu Y; Peng XC; Xu JN; Zheng MJ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1016-1022. PubMed ID: 36008294
[No Abstract] [Full Text] [Related]
40. Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.
Tsuboi N; Ernandez T; Li X; Nishi H; Cullere X; Mekala D; Hazen M; Köhl J; Lee DM; Mayadas TN
Arthritis Rheum; 2011 Feb; 63(2):467-78. PubMed ID: 21280001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
